Mangoceuticals, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Mangoceuticals, Inc. (MGRX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 2.00 million shares for the 12-month period ending 2025-12-31, per its 10-Q filed 2026-08-13.
Financial Statements › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-13
- Mangoceuticals, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 0.00 shares.
- Mangoceuticals, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-12-31 was 0.00 shares, a 100.00% decline year-over-year.
- Mangoceuticals, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2023-12-31 was 83.33K shares.
- Mangoceuticals, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 13.33K shares, a 85.71% decline from fiscal 2023.
- Mangoceuticals, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 93.33K shares, a 92.53% decline from fiscal 2022.
- Mangoceuticals, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 1.25M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | 0.00 shares derived: 10-Q 12 month − 10-Q 9 month · filed 2026-08-13 | 2.00M shares 10-Q · filed 2026-08-13 | |||
| 2025-09-30 | 2.00M shares 10-Q · filed 2025-11-14 | ||||
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | 13.33K shares 10-K · filed 2026-04-01 | |||
| 2024-09-30 | 13.33K shares 10-Q · filed 2024-11-14 | ||||
| 2023-12-31 | 83.33K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | 93.33K shares 10-K · filed 2025-03-20 | 1.40M shares 10-K · filed 2024-04-01 | ||
| 2023-09-30 | 10.00K shares 10-Q · filed 2024-11-14 | 150.00K shares 10-Q · filed 2023-10-27 | |||
| 2022-12-31 | 1.25M shares 10-K · filed 2024-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |